Proteomic Trajectory Mapping of Retinopathy of Prematurity
早产儿视网膜病变的蛋白质组轨迹图谱
基本信息
- 批准号:7314206
- 负责人:
- 金额:$ 21.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAdultAppendixApplications GrantsBioinformaticsBiologicalBiological AssayBirthCellsClinical TreatmentConditionDataDevelopmentDiseaseExperimental Animal ModelGene ExpressionGene ProteinsGene TargetingGoalsHealth SciencesHemorrhageHumanHuman Genome ProjectHyperoxiaImmunohistochemistryInvestigationKineticsLaboratoriesLocationMapsMessenger RNAMethodsModelingMolecularMolecular BiologyMonitorMusNeural RetinaOxygenPathogenesisPathway interactionsPharmaceutical PreparationsPolymerase Chain ReactionPremature InfantProcessProteinsProteomicsProtocols documentationPurposeResearch Project GrantsRetinaRetinalRetinal DegenerationRetinal DetachmentRetinal DiseasesRetinal NeovascularizationRetinopathy of PrematurityRodent ModelScienceStagingSystemTimeUniversitiesWestern Blottingdrug developmentinsightinterdisciplinary collaborationmouse modelnew technologynovelnovel strategiespostnatalprotein expressionresearch studytooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): The vertebrate retina undergoes drastic transformation after birth into the fully functional adult form. During postnatal development the proliferation of retinal cells and network formation in the neural retina take place. Healthy development is crucial to the full manifestation of retinal function in the adult stage. Exposure of premature infants to hyperoxia, upon returning to a normal oxygen level (normoxia), causes retinopathy. This disease is called "retinopathy of prematurity" or ROP. ROP is triggered by the retinal neovascularization induced by the normoxia after the hyperoxic condition is removed, and the consequent ophthalmologic complications takes place including bleeding, invasion of new vessels to outside of the retina, and finally retinal detachment. The rodent model of Oxygen Induced Retinopathy (OIR) is widely utilized as an experimental animal model for human ROP. Our long term goal is to understand the molecular pathways underlying the retinopathy using the mouse model of OIR and to use the model to establish an assay protocol to evaluate drugs that would suppress the progress of ROP. For this purpose we use a novel technology called "Proteomic Trajectory Mapping" that has been developed by the PI's group. Proteomic trajectory mapping describes the expression of each retinal protein along the developmental time axis. We hypothesize that ROP will be manifested in the alterations of the proteomic trajectories and certain drugs will reverse the alteration process. To evaluate this hypothesis, we will use the mouse model of OIR and propose the following three aims in the two year period. Specific Aim 1: To define proteomics trajectories in the mouse model of OIR in comparison to normal retinal development. Specific Aim 2: Expression of the key proteins and genes underlying the retinal development and its alteration in OIR will be investigated both at the protein level by western blot and at the mRNA level by real- time PCR. Specific Aim 3: Cellular localization of six transcription factors/regulators which have been identified by our proteomics experiments will be investigated by immunohistochemistry in both normal and OIR retinas. Achievement of these aims will give us crucial information on the molecular pathways that are involved in the pathogenesis of ROP. The results will contribute significantly to the development of drugs for the treatment of ROP and other related retinal diseases.
描述(由申请人提供):脊椎动物视网膜在出生后经历剧烈的转变,成为功能齐全的成年形式。在出生后的发育过程中,视网膜细胞增殖并在神经视网膜中形成网络。健康的发育对于成年期视网膜功能的充分表现至关重要。早产儿暴露于高氧,一旦恢复到正常氧水平(常氧),会引起视网膜病变。这种疾病被称为“早产儿视网膜病变”或ROP。ROP是由高氧条件消除后常氧诱导的视网膜新生血管形成引发的,并且随之发生的眼科并发症包括出血、新血管侵入视网膜外,最终发生视网膜脱离。氧诱导视网膜病变(OIR)的啮齿动物模型被广泛用作人类ROP的实验动物模型。我们的长期目标是使用OIR小鼠模型来了解视网膜病变的分子途径,并使用该模型建立测定方案来评估抑制ROP进展的药物。为此,我们使用了一种新的技术,称为“蛋白质组学轨迹映射”,已开发的PI的小组。蛋白质组学轨迹映射描述了每个视网膜蛋白质沿发育时间轴的表达。我们假设ROP将表现在蛋白质组轨迹的改变中,某些药物将逆转改变过程。为了评估这一假设,我们将使用OIR的小鼠模型,并提出以下三个目标,在两年内。具体目标1:定义与正常视网膜发育相比OIR小鼠模型中的蛋白质组学轨迹。具体目标二:在蛋白质水平上通过蛋白质印迹和在mRNA水平上通过真实的-时间PCR来研究视网膜发育及其在OIR中的改变的基础的关键蛋白质和基因的表达。具体目标3:细胞定位的六个转录因子/调节,已确定我们的蛋白质组学实验将在正常和OIR视网膜免疫组化研究。这些目标的实现将为我们提供有关ROP发病机制的分子途径的重要信息。本研究结果将为ROP及其他相关视网膜疾病的治疗药物的开发做出重要贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIROYUKI MATSUMOTO其他文献
HIROYUKI MATSUMOTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIROYUKI MATSUMOTO', 18)}}的其他基金
COBRE: OUHSC: PROTEOMICS/BIOINFORMATICS CORE
COBRE:OUHSC:蛋白质组学/生物信息学核心
- 批准号:
7959973 - 财政年份:2009
- 资助金额:
$ 21.51万 - 项目类别:
COBRE: OUHSC: PROTEOMICS/BIOINFORMATICS CORE
COBRE:OUHSC:蛋白质组学/生物信息学核心
- 批准号:
7720536 - 财政年份:2008
- 资助金额:
$ 21.51万 - 项目类别:
COBRE: OUHSC: PROTEOMICS/BIOINFORMATICS CORE
COBRE:OUHSC:蛋白质组学/生物信息学核心
- 批准号:
7610502 - 财政年份:2007
- 资助金额:
$ 21.51万 - 项目类别:
Proteomic Trajectory Mapping of Retinopathy of Prematurity
早产儿视网膜病变的蛋白质组轨迹图谱
- 批准号:
7498455 - 财政年份:2007
- 资助金额:
$ 21.51万 - 项目类别:
COBRE: OUHSC: PROTEOMICS/BIOINFORMATICS CORE
COBRE:OUHSC:蛋白质组学/生物信息学核心
- 批准号:
7381941 - 财政年份:2006
- 资助金额:
$ 21.51万 - 项目类别:
COBRE: OUHSC: PROTEOMICS/BIOINFORMATICS CORE
COBRE:OUHSC:蛋白质组学/生物信息学核心
- 批准号:
7171161 - 财政年份:2005
- 资助金额:
$ 21.51万 - 项目类别:
COBRE: OUHSC: PROTEOMICS/BIOINFORMATICS CORE
COBRE:OUHSC:蛋白质组学/生物信息学核心
- 批准号:
6982238 - 财政年份:2004
- 资助金额:
$ 21.51万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 21.51万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 21.51万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 21.51万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 21.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 21.51万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 21.51万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 21.51万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 21.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 21.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 21.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




